Starting to add again.Especially since they are now loaded up with cash (about $ 1.67 in cash, per share o/s...low float)
News of a CRO on their 40 person Covid Study soon. Maybe a few anecdotal stories to go along with it?
Last raise was at $ 9 (which brought in $ 17M) . Being a value investor, I will add at prices between $ 2.50 and $ 3.50.
The story sells. Removing deadly viruses from blood (including Covid) via filtration.
Who knows when the next spike will happen ?
MM